Shots:

• The P-lll study involves assessing of Sputnik V vaccine vs PBO from 19-866 volunteers with COVID-19. The efficacy of the vaccine is 92% effective in fighting COVID-19 based on peer-reviewed late-stage trial results published in the lancet international medical journal
• Previous data from two-dose regimen of the vaccine based on two different viral vectors administered 21 days apart indicates 91.6% effective against symptomatic COVID-19
• The findings from Gamaleya Institute in Moscow that developed and tested the vaccine with efficacy data reported at earlier stages of the trial running in Moscow since Sept’2020

 ­ Ref: Reuters | Image: Dawn